Building Institutional Capacity to Improve HIV-TB Care and Treatment Service Quality in India under the President's Emergency Plan for AIDS Relief (PEPFAR)

Post Date

August 29th 2014

Application Due Date

October 15th 2014

Funding Opportunity Number

CDC-RFA-GH15-1540

CFDA Number(s)

93.067

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

2

Eligibility Categories

Other

Eligible applicants that can apply for this FOA are listed below: Government Organizations: ╔ National Ministries of Health ╔ State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . ╔ American Indian/Alaska Native tribal governments (federally recognized or state-recognized) ╔ Political subdivisions of States (in consultation with States) Non-government Organizations: ╔ American Indian/Alaska native tribally designated organizations ╔ Alaska Native health corporations ╔ Tribal epidemiology centers ╔ Urban Indian health organizations ╔ Nonprofit with 501C3 IRS status (other than institution of higher education) ╔ Nonprofit without 501C3 IRS status (other than institution of higher education) ╔ Research institutions (that will perform activities deemed as non-research) Colleges and Universities Community-based organizations Faith-based organizations For-profit organizations (other than small business) Hospitals Small, minority, and women-owned businesses All Other eligible organizations

Funding

• Estimated Total Funding:

  $0

• Award Range:

  $0 - $750000

Grant Description

India is home to the third largest number of people living with HIV/AIDS (PLWH) in the world. There are an estimated 2.09 million people living with HIV. The Government of India (GoI) has undertaken a robust scale up of its antiretroviral treatment (ART) program, starting from eight ART centers in 2004 to over 420 centers now in 2014. Currently, over 750,000 PLWH are on ART out of 1.1 million eligible for treatment. Despite scale up success, several challenges remain for the ART program to achieve the expansion it envisages over the next five years. These include human capacity issues, loss of patients from detection to enrollment in HIV care, and late HIV detection and retention. At every stage, over 200,000 patients are lost from testing to enrollment in care, to retention in care and then to treatment. Although progress has been made in the implementation of the HIV-TB program, there are several gaps that need to be addressed. The linkages between HIV/AIDS and the Revised National Tuberculosis Control Program (RNTCP) are suboptimal, particularly in northern states due to limited capacity and infrastructure. Only 61% (2014) of TB patients were screened for HIV and knew their HIV status in the last one year. Of those identified as HIV positive, 85% were linked to ART. However, the concern is that the referral from HIV testing and care facilities to RNTCP is quite low.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC Procurement and Grants Office
  Technical Information Management Section
  E-mail: pgotim@cdc.gov
  Phone: 770-488-2700
  

• Agency Mailing Address:

  `PGO TIM

• Agency Email Address:

  pgotim@cdc.gov